首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Pharmaceutical research

缩写:PHARM RES-DORDR

ISSN:0724-8741

e-ISSN:1573-904X

IF/分区:4.1/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引4211
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Feng Shi,Qingmei Hu,Yiquan Lin et al. Feng Shi et al.
Background: Thrombotic diseases remain a major global health burden. Current anticoagulants are often limited by bleeding risks and narrow therapeutic windows, largely due to their single-target mechanisms. In contrast, m...
Nishant S Kulkarni,Roshan James,Aishwarya Saraswat et al. Nishant S Kulkarni et al.
Objective: Polymeric microspheres (MS) have been developed with moderate success using aqueous emulsification (AqE) for small molecules and peptides with a few approved products. AqE faces a challenge to achieve optimal e...
Takuya Fujita,Yukari Kamikozawa,Makoto Ozawa et al. Takuya Fujita et al.
Objective: The purpose of this study is to analyze the impact of the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB) transport characteristics of drugs on their intracerebral distribution in male c...
Mirette Mina,Zhen Zhang,Wanjie Sun et al. Mirette Mina et al.
Purpose: U.S. Food and Drug Administration (FDA) recommends reference scaled limits and variability comparison for bioequivalence (BE) demonstration of narrow therapeutic (NTI) drugs while most other regulatory agencies a...
Jordan D Pritts,Uriel Ortega-Rodriguez,V Ashutosh Rao Jordan D Pritts
Background: While photostability testing conditions for biologics are often based on small molecule standards, the unique characteristics of proteins necessitate a deeper understanding of appropriate testing and controls....
Preshita Desai,Katherine Bang,Mohammed Riaz Hasan Chowdhury et al. Preshita Desai et al.
Objective: Lung cancer chemoprevention modalities are gaining wide attention as it is the second most diagnosed cancer type and the leading cause of cancer-related deaths. Our previous studies reported unique lung cancer ...
Mahsa Jahed,Janusz Kozinski,Leila Pakzad Mahsa Jahed
Objective: The effectiveness of pressurized metered-dose inhalers (pMDIs) relies on correct inhalation technique. While prior studies investigated idealized breathing, the impact of real-life irregularities remains less u...
Chunlai Feng,Wen Deng,Min Cai et al. Chunlai Feng et al.
Objective: Bioactive peptides derived from natural or synthetic sources have shown significant potential for cancer therapy; however, their clinical application is often limited by poor tumor selectivity and systemic toxi...
Sangita A Kale,Savita S Deokar,Karimunnisa S Shaikh Sangita A Kale
Introduction: Sorafenib (SOR) is a low-dose multikinase inhibitor that suppresses angiogenesis by blocking vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptors. The aim of the pres...